Effect of Sulpiride in Endogenous Depression
- 1 January 1984
- journal article
- clinical trial
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 69 (S311) , 43-48
- https://doi.org/10.1111/j.1600-0447.1984.tb06858.x
Abstract
Clinical practice and pharmacological data suggest a possible antidepressive action of sulpiride given in low dosages. To further explore the therapeutic efficacy of sulpiride 11 patients with an endogenous type of depression were studied during treatment with an oral daily dose of 150 mg sulpiride. The present data allows the conclusion that (A) low dosed sulpiride seems to act as an antidepressant in severe and milder forms of depression, (B) a clinical progress is seen earlier than is common during treatment with tricyclics and (C) a significant increase of drive is observable. However, sulpiride maintenance therapy did not prevent early relapse into depression. The preliminary nature of these clinical observations does not allow conclusions about the ultimate utility of this drug. Moreover, it remains unclear for which patients sulpiride is appropriate or perhaps superior to conventional treatment modalities of depression.Keywords
This publication has 8 references indexed in Scilit:
- A clinical and pharmacodynamic evaluation of sulpiridePsychopharmacology, 1981
- Electroconvulsive Shock: Progressive Dopamine Autoreceptor Subsensitivity Independent of Repeated TreatmentScience, 1980
- Differential actions of substituted benzamides on pre- and postsynaptic dopamine receptor mechanisms in the nucleus accumbensJournal of Pharmacy and Pharmacology, 1980
- The substituted benzamides - a novel class of dopamine antagonistsLife Sciences, 1979
- Sulpiride in stuporPsychopharmacology, 1972
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960
- THE ASSESSMENT OF ANXIETY STATES BY RATINGPsychology and Psychotherapy: Theory, Research and Practice, 1959